HOW WE USE THE FUNDS

The Bietti Foundation has been recognized as a scientific institution for hospitalisation and care by ministerial decree of 15 February 2005, subsequently confirmed from time to time by the same measure. For scientific research activities, the Foundation receives contributions from both public and private bodies.

5 X 1000

In compliance with art.16 paragraph 5 of the Prime Ministerial Decree 23/07/2020 the IRCCS G.B. Bietti Foundation for the Study and Research in Ophthalmology ONLUS  (Tax Code 07864670588) publishes the amount of the contributions of 5×1000 collected during 2020.

Each year, the Scientific Director informs the Scientific Committee of the possibility of the 5×1000 contribution and initiates a consultation procedure among the researchers of the Research Units, inviting them to express interest in accessing these resources in order to support new research projects. Those responsible for the lines of research concerned must submit their project proposals to the Scientific Director. The proposals collected are submitted to the Scientific Committee for evaluation. At the end of the evaluation, the Scientific Director approves the ranking of the projects and assigns the available resources according to the ranking position. Eligible but non-fundable projects are also identified, which may be financed later, in accordance with the ranking order, if additional financial resources are made available from other income.

Operating grants

Currently, public contributions are provided by the Ministry of Health, in the form of an annual contribution for current research.

Rome Foundation, the majority shareholder of Bietti Foundation, provides an annual contribution on an annual basis to support research activities (90% of the contribution) and to cover structural costs (10%).

Thanks to the above contributions, the Foundation covers the costs of current activities related to research, such as personnel costs, purchase of goods and services, renting and leasing, etc.

Sponsored Studies

The Foundation, in line with its mission, carries out clinical trial activities through the stipulation of specific contracts with private subjects (Sponsors), who under their own responsibility, commission and/or finance a clinical trial.

Spontaneous studies with external funding

The Foundation enters into agreements with companies in the sector, interested in research and development in the field of ophthalmology, for spontaneous studies that provide funding to cover the costs of the project.

Capital contributions

The Foundation can benefit from capital contributions, aimed at the purchase of the latest generation of instruments for scientific purposes.

Capital contributions for the purchase of scientific instruments can be paid  by the Ministry of Health, through participation in a call for bids; the Ministry finances all or part of the purchase of the instrumentation to the winners.

Over the years, Fondazione Roma has also helped to finance purchases, up to 90% of the cost, of important scientific instruments.

Fondazione Roma has contributed (up to 90% of the cost) to finance the following instruments (the most significant below):

  • Leica surgical microscope: total cost 182,268. Contribution FR € 164.041,20
  • High Performance Liquid Chromatography (HPLC), total cost 181,687.98. Contribution FR 163,519.57
  • Instrumentation “Tomograph/topographer/pupillometer SM39”: total cost of € 73,200.00. Contribution FR € 63.000,00;
  • EIBOS 2 instrumentation, total cost € 44,442.16. Contribution FR € 30.964;
  • Laser Lightlas SLT Deux: € 50,532.85. Contribution FR € 45.119,57

Capital Account Ministry of Health

Digital diagnostic platform for the non-invasive evaluation in multifluorescence integrated to the analysis of vascular flows for ocular neoplasms, amount financed €195,200.00, with which the following instrumentation was purchased:

  1. Heidelberg SPECTRALIS COMBO2 MC OCTA system with the following modules:
    • SLO module for IR-AF-FA-NIR-ICG-MULTICOLOR:
    • High-definition OCT 85000 Hz module;
    • OCTA MODULE for Angio OCT Full Spectrum Amplitude Decorrelation (FSADA)

Optimization of the morphological and functional results of vitreoretinal surgery: early diagnosis, assessment of damage progression and reduced trauma in vitreoretinal surgery, amount financed €210,828.20, with which the following instrumentation was purchased:

  1. NGENUITY 3D VISION SYSTEM
  2. CIRRUS HD-OCT 5000
  3. Nidek MP3 Microperimeter
  4. Vantage Plus Led Indirect Wireless Ophthalmoscope with Slimline Lithium Battery and Charger

Treatment with micropulsed sub-threshold laser PASCAL SYNTHESIS 577™ in retinal diseases with high social impact: evaluation of its clinical application through the functional study of the retina and nerve conduction along the optical pathways through the RETIMAX ADVANCED PLUS apparatus, amount financed €167,506.00, with which the following instrumentation was purchased:

  1. PASCAL Synthesis 577 Retinal Laser
  2. RETIMAX ADVANCED PLUS

 

Functional System for the study of the phenotype-genotype correlation of hereditary ocular diseases by means of high-resolution imaging, amount financed €512,998.00, with which the following instrumentation was purchased:

  1. OPTOS SILVERSTONE SS OCT
  2. KONAN CELLCHEK C MIRROR MICROSCOPE
  3. CFX OPUS 96 DX REAL TIME PCR SYSTEM BIORAD

The Fondazione Rom has contributed (up to 90% of the cost) to finance the following instruments (the most significant below):

  • Leica operating microscope: total cost 182,268. FR contribution: 164,041.20
  • High Performance Liquid Chromatography (HPLC), total cost 181,687.98. Contribution FR 163,519.57,
  • instrumentation “Tomograph/topograph/pupillometer SM39”, for a total of € 73,200. FR contribution: € 63,000.
  • eIBOS instrumentation 2, total cost 44,442.16. Contribution FR 30.964;
  • Laser Lightlas SLT Deux, € 50,532.85. Contribution FR 45.119,57.